The Thymosin beta 4 peptide is a complex molecule with various potential biological roles including tissue repair and regeneration, angiogenesis, anti-inflammatory actions and neuroprotection.

Positive clinical trial results for a drug candidate to treat lung cancer sent shares of this unprofitable biotech firm ...

A computational model of skeletal muscle regeneration reveals complex interplay of cytokines, angiogenesis, and cell behaviors, predicting that synergistic cytokine perturbations enhance skeletal ...

Endothelial cells play an important role in angiogenesis—the formation of new blood vessels. A tumor’s blood vessels differ ...

Ranibizumab is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment directed against human vascular ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The FRUTIGA trial results published by Nature Medicine suggest that fruquintinib could be another effective treatment option for gastric cancer patients. FRUTIGA was a 1:1 randomized, double-blind, ...

Chemically speaking, B7-33 is a synthetic SARM or selective androgen receptor modulator. Preclinical research has indicated that it may have anabolic potential on skeletal muscle, with mechanisms of ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that the Company received and accepted an unsolicited offer from an institutional investor to purchase 22,222 ...

In this report, we will discuss some of the AACR data relating to angiogenesis in light of previous results from clinical trials, attempting to outline what has been achieved so far and what are ...